European Monthly Measles Monitoring Report, September 2011
In September, the coordination of surveillance of measles and other vaccine-preventable diseases at the European level was transferred from Statens Serum Institut in Denmark (the previous coordinating agency for the EUVAC.NET hub) to ECDC and countries started reporting to The European Surveillance System (TESSy).
Since the last European monthly measles monitoring report (EMMO) published on 16 September, nearly 800 new measles cases were detected in the EU and EEA/EFTA countries. This brings the total number of cases in 2011 to more than 29 100. No new measles outbreaks were reported during September and transmission has continued to slow down in the second half of the year.
Measles, a highly infectious vaccine-preventable disease, is re-emerging in Europe. Countries within the European Region of the World Health Organization, which include EU and EEA/EFTA countries, have committed to eliminate measles by 2015. Elimination of measles requires sustained vaccination coverage above 95% with two doses of a measles-containing vaccine (MCV).
ECDC is monitoring measles transmission in these countries and produces epidemiological updates. The EMMO aims to provide timely public updates on the measles situation in Europe for effective disease control measures, and in support of the common 2015 measles elimination target.
In September, the coordination of surveillance of measles and other vaccine-preventable diseases at European level was transferred from the Statens Serum Institut in Denmark (the former EUVAC.NET hub coordinator) to ECDC and countries started reporting to The European Surveillance System (TESSy). At the same time, the EUVAC.NET website migrated to the ECDC website. This is the first edition of the EMMO presenting data reported by countries to TESSy
Antimicrobial consumption - Annual Epidemiological Report for 2019
18 Nov 2020 - In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.
Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report for 2019
18 Nov 2020 - This report is based on data reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) for the period 2015 to 2019, retrieved from The European Surveillance System (TESSy) and ECDC’s decentralised data storage for antimicrobial resistance and healthcare-associated infections (ARHAI) on 10 September 2020.
Influenza virus characterisation, October 2020
13 Nov 2020 - This is the first report for the 2020–2021 influenza season. As of week 44/2020, only 39 influenza detections across the WHO European Region had been reported to The European Surveillance System (TESSy); 59% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 41% type B viruses with none having been ascribed to a lineage. This represents a 97% drop in detections compared with the same period in 2019, probably due to the COVID-19 pandemic and measures introduced to combat it.